In silico comparative analysis of curcumin and acarbose as inhibitors of human pancreatic alpha-amylase

Simple item page
dc.contributor.authorBadullewa,Chamika
dc.contributor.authorRodrigo, U. A. A
dc.date.accessioned2026-09-20T10:03:40Z
dc.date.available2026-09-20T10:03:40Z
dc.date.issued2026-05-02
dc.descriptionAbstract No: 2025_443 Page No 99
dc.description.abstractHuman pancreatic α-amylase is an important therapeutic target for drug development to control postprandial blood glucose levels in Type 2 Diabetes Mellitus (T2DM).
dc.identifier.issn1012-8999
dc.identifier.urihttps://dr.ichemc.ac.lk/handle/123456789/490
dc.language.isoen
dc.publisherInstitute Of Chemistry Ceylon
dc.relation.ispartofseries43 ; 2
dc.subjectAlpha-amylase
dc.subjectCurcumin
dc.subjectMolecular Docking
dc.subjectType 2 Diabetes
dc.subjectEthnopharmacolog
dc.titleIn silico comparative analysis of curcumin and acarbose as inhibitors of human pancreatic alpha-amylase
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
In silico comparative analysis of curcumin and acarbose.pdf
Size:
648.61 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Abstract